Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.


A 68-year-old patient developed increasingly frequent episodes of ventricular and supraventricular arrhythmias over the past five years. During the last 12 months, he was admitted to the hospital on several occasions with complex arrhythmias including multifocal PVCs, bigeminy, trigeminy, ventricular tachycardia, and atrial flutter and fibrillation. Large… (More)


  • Presentations referencing similar topics